We provide you with 20 years of free, institutional-grade data for ASMB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ASMB. Explore the full financial landscape of ASMB stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$674
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Sale | -29 | $23.25 | $674 | 2026-06-18 |
| White Nicole S | Grant, award...etc | 14,000 | 2026-06-05 | ||
| Bjorkquist Jeanette M | Grant, award...etc | 3,500 | 2026-06-05 | ||
| Delaney William E IV | Grant, award...etc | 14,000 | 2026-06-05 | ||
| Okazaki Jason A | Grant, award...etc | 50,750 | 2026-06-05 | ||
| Gaggar Anuj | Grant, award...etc | 14,000 | 2026-06-05 | ||
| GILEAD SCIENCES, INC. | Grant, award...etc | 471,698 | $26.5 | 2026-05-27 | |
| White Nicole S | Sale | -197 | $26.65 | $5,250 | 2026-03-31 |
| White Nicole S | Grant, award...etc | 26,000 | 2026-03-31 | ||
| Gaggar Anuj | Grant, award...etc | 26,000 | 2026-03-31 | ||
| Delaney William E IV | Grant, award...etc | 26,000 | 2026-03-31 | ||
| Okazaki Jason A | Grant, award...etc | 94,250 | 2026-03-31 | ||
| Bjorkquist Jeanette M | Sale | -328 | $26.65 | $8,741 | 2026-03-31 |
| Bjorkquist Jeanette M | Grant, award...etc | 6,500 | 2026-03-31 | ||
| GILEAD SCIENCES, INC. | Open Market Purchase | 4,591,840 | 2025-10-03 |
The information provided in this report about ASMB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Assembly Biosciences, Inc(NASDAQ:ASMB) 
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H21...
Website: http://www.assemblybio.com
Founded: 2005
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology